4N9-97047-93763

2 vaccinations 5 coded responses 11 check-ins 5 free-text entries 5 call cases

Sex: Female
Age at first dose: 61-65
ZIP prefix: 322 / FL
Registered: 2021-01-14

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-14
Registered in v-safe
2021-01-14
Dose 2 — Pfizer-BioNTech
2021-01-14
Survey response — day 0, dose 2
MedDRA: COVID-19, Emergency care, Fatigue, SARS-CoV-2 test positive — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Systemic reaction (other): Im day 22 after a positive Covid test. Todays fatigue is d/t Covid recovery · Healthcare visit (other): Covid dc after first injection. ED visit after diagnosis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — day 0, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Eye irritation — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Burning eyes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-01-18
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-19
Survey response — days 1–6 daily, dose 2
MedDRA: Medical counselling — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Message sent to PCP

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-01-24
Health check-in — day 7, dose 2
Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-05
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-02-12
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-18
Survey response — day 35, dose 2
MedDRA: COVID-19, Exposure to SARS-CoV-2, Gastrointestinal bacterial overgrowth, Gastrointestinal disorder, Medical counselling, Office visit, Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Symptoms of small intestine bacterial overgrowth. These are left over side effects from having Covid.Exposure to someone who became Covid positive. I Experience G.I. symptoms two days later. Employee Health told me that I did not need a Covid test · Healthcare visit (other): Communicated with the position through the portal

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-18
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-02
Survey response — day 42, dose 2
MedDRA: Gastrointestinal disorder, Injection site pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Increase in G.I. symptoms. Recurrence of injection site soreness. Employer declined a Covid test and said that the test would be positive for 20 days due to Covid two months ago.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-16
Call 1 — Left Voicemail
2021-04-18
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-14	Pfizer-BioNTech

Call center

5 call center cases

5 unsuccessful

See the call center timeline

Free text

Release 2 — day 0, dose 2

2021-01-14

Systemic reaction (other): Im day 22 after a positive Covid test. Todays fatigue is d/t Covid recovery

Healthcare visit (other): Covid dc after first injection. ED visit after diagnosis

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): Burning eyes

2021-01-19

Healthcare visit (other): Message sent to PCP

Release 4 — day 35, dose 2

2021-02-18

Symptoms: Symptoms of small intestine bacterial overgrowth. These are left over side effects from having Covid.Exposure to someone who became Covid positive. I Experience G.I. symptoms two days later. Employee Health told me that I did not need a Covid test cut off by CDC

Healthcare visit (other): Communicated with the position through the portal

Release 4 — day 42, dose 2

2021-03-02

Symptoms: Increase in G.I. symptoms. Recurrence of injection site soreness. Employer declined a Covid test and said that the test would be positive for 20 days due to Covid two months ago.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	COVID-19	✓	✓	✓
HCVO	Emergency care	✓	✓	✓
HCVO	Medical counselling	✓	✓	✓
HCVO	Unevaluable event	○	✓	○
SD	COVID-19	✓	·	✓
SD	Exposure to SARS-CoV-2	✓	✓	✓
SD	Gastrointestinal bacterial overgrowth	✓	✓	✓
SD	Gastrointestinal disorder	✓	✓	✓
SD	Injection site pain	✓	✓	✓
SD	Office visit	✓	·	✓
SRO	Eye irritation	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	SARS-CoV-2 test positive	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release